Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma-derived von Willebrand factor

被引：0
|
作者：
Tran, Thuy B. [1 ]
Arnall, Justin R. [1 ]
Kleiboer, Brendan [2 ]
Hinson, Ashley [2 ]
机构：
[1] Atrium Hlth, Dept Pharm, Specialty Pharm Serv, 4400 Golf Acres Dr,Bldg J,Suite B1, Charlotte, NC 28208 USA
[2] Atrium Hlth, Levine Childrens Canc & Blood Disorder, Levine Canc Inst, Charlotte, NC USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷 / 02期
关键词：
DESENSITIZATION;
D O I：
10.1002/pbc.29918
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
    Schwarz, HP
    Dorner, F
    Mitterer, A
    Mundt, W
    Schlokat, U
    Pichler, L
    Turecek, PL
    HAEMOPHILIA, 1998, 4 : 53 - 62
  • [42] In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease
    Turecek, PL
    Gritsch, H
    Pichler, L
    Auer, W
    Fischer, B
    Mitterer, A
    Mundt, W
    Schlokat, U
    Dorner, F
    Erinkman, HJM
    vanMourik, JA
    Schwarz, HP
    BLOOD, 1997, 90 (09) : 3555 - 3567
  • [43] Pharmacokinetics of a Recombinant Von Willebrand Factor in Patients with Severe Von Willebrand Disease
    Ragni, Margaret V.
    Castaman, Giancarlo
    Gill, Joan Cox
    Kouides, Peter
    Chapman, Miranda
    Sytkowski, Arthur
    Obermann-Slupetzky, Ortrun
    Presch, Isabella
    Fritsch, Sandor
    Ewenstein, Bruce M.
    BLOOD, 2015, 126 (23)
  • [44] Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor
    Peyvandi, Flora
    Kouides, Peter
    Turecek, Peter L.
    Dow, Edward
    Berntorp, Erik
    BLOOD REVIEWS, 2019, 38
  • [45] PHARMACOKINETIC MODELING OF THE VON WILLEBRAND FACTOR - FACTOR VIII INTERACTION IN PERIOPERATIVE VON WILLEBRAND DISEASE PATIENTS
    Bukkems, L. H.
    Heijdra, J.
    de Jager, N.
    Hazendonk, H.
    Fijnvandraat, K.
    Meijer, K.
    Eikenboom, J.
    Laros-van Gorkom, B.
    Leebeek, F.
    Cnossen, M.
    Mathot, R.
    HAEMOPHILIA, 2021, 27 : 147 - 147
  • [46] REAL-WORLD EFFICACY AND SAFETY OF PLASMA-DERIVED VON WILLEBRAND FACTOR-CONTAINING FACTOR VIII CONCENTRATES IN PATIENTS WITH VON WILLEBRAND DISEASE IN ITALY
    Federici, A. B.
    Mairal, E.
    HAEMOPHILIA, 2023, 29 : 145 - 146
  • [47] Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy
    Federici, Augusto B.
    Santoro, Rita Carlotta
    Santoro, Cristina
    Pieri, Lisa
    Santi, Roberto Mario
    Barillari, Giovanni
    Borchiellini, Alessandra
    Tosetto, Alberto
    Zanon, Ezio
    De Cristofaro, Raimondo
    Mairal, Esther
    Mir, Roser
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [48] The Empower Study - Design of a Randomized Clinical Trial to Assess the Efficacy and Safety of a Plasma-Derived Von Willebrand Factor / Factor VIII Concentrate for Heavy Menstrual Bleeding in Women with Von Willebrand Disease
    Sholzberg, Michelle
    Tang, Grace H.
    James, Paula D.
    Meffe, Filomena
    Rimmer, Emily
    Jackson, Shannon
    Sun, Haowei Linda
    Robinson, Sue
    Floros, Georgina
    Aratia, Shamshah
    Juni, Peter
    da Costa, Bruno R.
    BLOOD, 2022, 140 : 8483 - 8484
  • [49] Soluble plasma-derived von Willebrand factor assembles to a halemostatically active filamentous network
    Barg, Alexej
    Ossig, Rainer
    Goerge, Tobias
    Schneider, Matthias F.
    Schillers, Hermann
    Oberleithner, Hans
    Schneider, Stefan W.
    THROMBOSIS AND HAEMOSTASIS, 2007, 97 (04) : 514 - 526
  • [50] ADAMTS13 Content of Plasma-Derived Factor VIII-Von Willebrand Factor Concentrates
    Peyvandi, Flora
    Mannucci, Pier Mannuccio
    Valsecchi, Carla
    Pontiggia, Silvia
    Bernstein, Jonathan
    Guazzini, Stefano
    Retzios, Anastassios
    BLOOD, 2012, 120 (21)
12345